Dipeptidyl peptidase IV (DDPIV) modulates glucose hemostasis by cleavage of glucagon-like peptide 1 (GLP-1) and DDPIV inhibitors are used for type 2 diabetes treatment. Here, GCG is linked to type 2 diabetes mellitus.